Histamine from various sources is found in significant amounts around cerebral vessels and may play a significant role in controlling CBF. The effect of hista mine on the intracerebral microcirculation has not been examined. We have used an in vitro technique for the iso lation and cannulation of intracerebral arterioles from the rat to study the effect of histamine on the spontaneous tone developed by these vessels. Extraluminally adminis tered histamine caused dose-dependent vasodilation of Histamine is located in and around cerebral blood vessels in significant amounts. Mast cells lo cated in the meningeal investment of large cerebral arteries, resistance vessels, and veins contain hista mine (Edvinsson et ai., 1977; Jarrott et ai., 1979). Histamine is therefore likely to play a role in the response of the cerebral circulation to inflammation and injury. Non-mast cell histamine has also been localized to cerebrovascular smooth muscle (EI Ackad and Brody, 1974), and cerebral microvessels possess histamine binding sites (Peroutka et ai., 1980). Histamine is found in brain (Ronnberg et ai., 1973) and may function as a neurotransmitter (Schwartz et ai., 1980). Administered intraarterially after blood-brain barrier disruption, histamine in creases cerebral blood flow and cerebrovascular transport of sucrose and aminoisobutyric acid (Gross et aI., 1982). Perivasculariy applied hista mine dilates pial arteries in cats by activation of an H2 receptor (Wahl and Kuschinsky, 1979 
Histamine is located in and around cerebral blood vessels in significant amounts. Mast cells lo cated in the meningeal investment of large cerebral arteries, resistance vessels, and veins contain hista mine (Edvinsson et ai., 1977; Jarrott et ai., 1979) . Histamine is therefore likely to play a role in the response of the cerebral circulation to inflammation and injury. Non-mast cell histamine has also been localized to cerebrovascular smooth muscle (EI Ackad and Brody, 1974) , and cerebral microvessels possess histamine binding sites (Peroutka et ai., 1980) . Histamine is found in brain (Ronnberg et ai., 1973) and may function as a neurotransmitter (Schwartz et ai., 1980) . Administered intraarterially after blood-brain barrier disruption, histamine in creases cerebral blood flow and cerebrovascular transport of sucrose and aminoisobutyric acid (Gross et aI., 1982) . Perivasculariy applied hista mine dilates pial arteries in cats by activation of an H2 receptor (Wahl and Kuschinsky, 1979 ).
Gross and colleagues (Gross, 198 1; Gross et ai.,  isolated intracerebral arterioles with a maximal dilation of 139 ± 2.4% of control diameter. The dilation was blocked by the Hz receptor antagonist cimetidine. but was only incompletely attenuated by the HI receptor blocker chlorpheniramine. Histamine effects a dilation of the spontaneous tone of intracerebral resistance vessels. which is mediated by H2 receptors. Key Words: Cerebral microcirculation-Endothelial cells-Histamine-Va sodilation.
198 1 a, b) describe the significance of the distribu tion of histamine receptors in cerebral vessels and the change in number and type of histamine re ceptors as one proceeds through the cerebral mi crocirculation to the cerebral veins. Although it is known that histamine dilates larger pial vessels, its effect on intracerebral or penetrating arterioles has not been investigated. Most in vitro studies of his taminergic vasodilation in isolated cerebral arteries have been performed on precontracted prepara tions and not on the spontaneous tone of the vessel (Edvinsson et ai., 1983; Gross, 1984) .
The aim of this study is to examine histaminergic dilation of spontaneous contraction in intracerebral arterioles, a segment of the cerebral microcircula tion that has generally been inaccessible for direct physiological examination.
MATERIALS AND METHODS

Preparation of vessels
Penetrating intracerebral arterioles were isolated and cannulated in an organ bath, and changes in vessel diam eter in response to the extraluminal administration of agents were measured as described in detail previously (Duling et aI., 1981; Dacey and Duling, 1982) . Briefly, in tracerebral arterioles, approximately 900-\ ,000 f-lm in length, were surgically isolated from the brains of pento barbital-anesthetized male Sprague-Dawley rats weighing between 250 and 350 g. The vessels were transferred to the stage of an inverted microscope and were cannulated using glass pipettes; transmural pressure was set by ap plying a known pressure to the lumen of the cannulating pipette. Vessel diameters and wall thickness were deter mined using a video dimensional analysis system. The physiological salt solutions used in this preparation were modified Ringer solutions, whose compositions were as follows (in mM): NaCI 144, KCI 3.0, CaCI2 2.5, MgS04 1.5, glucose 5, pyruvate 2.0, ethylenediaminetetraacetic acid (EDTA) 0.02, 3-[N-morpholinolpropanesulfonic acid (MOPS) 2.0, NaH2P04 l.21, and bovine serum albumin 0.9-l.0 g/dl. MOPS-buffered solutions were used be cause it was critical to maintain a stable solution in the small chamber volume while performing optical diameter measurements on the vessels. The turbulence caused by solubilizing gas in bicarbonate-buffered solutions makes such measurements much more difficult. Intraluminal so lution pH was 7.30. The extraluminal solution contained no albumin, and pH was varied from 6.80 to 7.80 to as sess individual vessel reactivity.
Mter vessel cannulation, transmural pressure was set at 60 mmHg and was maintained constant throughout the experimental protocol. Bath temperature was brought to 37°C, and vessels were allowed to equilibrate for 45 min at an extraluminal bath solution pH of 7.30. During this period, vessels developed spontaneous tone, contracting to approximately 70% of maximal passive diameter.
Histamine and chlorpheniramine were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Cimeti dine was obtained from Smith, Kline and French.
Determination of histamine dose-response curve
After spontaneous tone had developed at intraluminal and extraluminal solution pH of 7.30, solutions of in creasing histamine concentration were sequentially added to the chamber. Approximately 5 ml of solution was flushed through the 1.3-ml chamber with each solu tion change. Vessel diameter was then monitored for a 4-5-min period at each histamine concentration. All di ameter changes in response to histamine occurred within 2 min of solution change. At each histamine concentra tion, solution pH was checked and did not vary from 7.30.
Histamine-cimetidine interaction
All drug solutions were prepared in MOPS-buffered physiological saline solution and were checked to assure that solution pH was 7.30 before instillation into the chamber. After each solution change, vessel diameter was continually measured for a period of 5 minutes. Baseline vessel diameter was determined in physiological saline solution at pH 7.30 and then the bath solution was changed to one containing cimetidine alone at 10-7 M. The bath solution was then changed to one containing 10-7 M cimetidine and 10-4 M histamine. Finally, the bath solution was changed back to 10-7 M cimetidine alone, and changed again to physiological saline solution without cimetidine. This sequence was repeated using 10-5 and 10-3 M cimetidine to determine the effect of dilation produced by 10-4 M histamine. At the end of the protocol, 10-4 M histamine with no blocker was adminis tered to the vessel.
In a separate series of vessels, a dose-response curve for cimetidine was determined by sequential addition of solutions of increasing cimetidine concentration to the vessel chamber. No histamine was added during this series.
Histamine-chlorpheniramine maleate interaction Baseline diameter was determined in physiological sa line solution at pH 7.30. Bath solution was then changed to 10-7 M chlorpheniramine alone, and then changed again to 10-7 M chlorpheniramine and 10-4 M histamine. Solutions were then changed to the chlorpheniramine so lution alone, and then to physiological saline solution. The sequence was repeated with 10-5 and 10-4 M chlor pheniramine.
Statistical analysis
Mean responses were compared by one-way analysis of variance and then individual differences were com pared by Student-Newman-Kuel's test. The level of sig nificance was p = 0.05. Values are expressed as mean ±I SEM.
RESULTS
Histamine dilated intracerebral arterioles of mean diameter 55.57 ± 3.94 flm at pH 7.30 (Fig. 1) . No pretreatment with vasoconstricting agonists was needed to observe dilation, and changes in di ameter were from the baseline spontaneous tone, which had developed in the vessel at pH 7.30 . A maximal response of 139 ± 2.4% of control diam eter was observed. The threshold dose was 10-7 M and the EC 5 0 was 5 x 10-6 M.
Cimetidine at concentrations of 10-5 and 10-3 M significantly inhibited the dilation induced by 10-4 M histamine (Fig. 2) . No inhibition was observed at 10-7 M cimetidine. Cimetidinc administered alone had no effect on vessel diameter at concentrations between 10-9 and 10-3 M (Fig. 3) . No inhibition of vasodilation by 10-4 M histamine was produced by chlorpheniramine at 10-7 and 10-5 M. but 10-4 M chlorpheniramine partially inhibited this dilation (29.4 ± 2.4% versus 41.5 ± 4.6% of control diam eter). Chlorpheniramine administered alone had no effect on vessel diameter at concentrations between 10-9 and 10-4 M, but did cause significant vaso constriction at 10-3 M, to 65. 0 ± 6.1% of control diameter.
DISCUSSION
The major finding of this study is that histamine produces significant vasodilation when applied to the abluminal surface of an isolated intracerebral arteriole. This dilation affects the tone spontane ously developed by the arteriole; no precontraction of the isolated vessel is necessary. The response to histamine was blocked by the H2 receptor blocker cimetidine in concentrations of 10-5 M. The H I re ceptor blocker chlorpheniramine did not block the histamine-induced dilation at 10-5 M and only at tenuated the response somewhat at 10-3 M. These findings confirm observations made in vivo (Wahl ;<) 13 and Kuschinsky, 1979; Gross, 1981; Gross et aI., 1981a Gross et aI., ,b, 1983 Gross et aI., , 1984 ) that histamine is a vasodilator in the cerebral microcirculation. However, this is the first examination of histaminergic dilation in an in vitro cerebrovascular preparation using sponta neous tone, and the first investigation of histamin ergic mechanisms in the most distal resistance vessels within the cerebral microcirculation. The degree of vasodilation observed in isolated intracerebral arterioles is quantitatively similar to that observed in pial arterioles studied in vivo. Wahl and Kuschinsky (1979) found that periadven titial application of histamine produced maximal di lation of cat pial arterioles (diameter 29-227 j.Lm) to diameters approximately 132% of control. Gross et al. (1981 b) reported a somewhat smaller maximal histamine response (128% of control diameter) in cat pial arteries, but impromidine, an H2 receptor agonist, produced maximal dilation of 43%, and threshold responses were seen at concentrations below 10-10 M. Reported EC 5 0 s for histamine in cat pial arterioles range between 10-7 and 10-6 M in cranial window preparations -concentrations slightly lower than the EC 5 0 seen in intracerebral arterioles in the present study (Wahl and Kus chinsky, 1979; Gross et aI., 1981b) . Gross et al. (1981a) also studied the response of the cerebral circulation to intracarotid infusion of histamine. After breakdown of the blood-brain barrier had been induced by urea injection, histamine, infused at a maximal rate of 60 mg min -I kg -I, produced a 53% increase in cerebral blood flow compared to control. The maximal dilation response observed in the present study (140% of control diameter at pH 7. 30) should correspond to a potential 284% in crease in cerebral blood flow, assuming a fourth power relationship between vascular conductance and vessel radius (or diameter). This calculation suggests that the increase in cerebral blood flow produced by intracarotid histamine infusion after blood-brain barrier disruption is not as large as it could be. Alternative explanations for this observa tion include (1) failure of intraarterially infused his tamine to achieve high enough concentrations at H2 receptors located in predominately abluminal sites (Gross, 1981) ; (2) heterogeneity of responsiveness of more proximal segments of the cerebral circula tion to histamine; and (3) offsetting systemic effects of histamine on cardiac output or systemic arterial pressure. Although the effects of histamine on the cerebral circulation as a whole are complex, this agent clearly appears to be a dilator in the pial and intracerebral microcirculation.
Our findings suggest that histaminergic dilation of intracerebral arterioles is principally mediated by H2 receptors and is consistent with other data from the cerebral and systemic microcirculation (Altura and Altura, 1974; Wahl and Kuschinsky, 1979; Brody, 1980; Gross, 1981; Gross et aI., 1981a Gross et aI., ,b, 1983 Gross et aI., , 1984 . Cimetidine had no effect on the in trinsic tone of these vessels and markedly de creased the dilation to 10-4 M histamine at 10-5 M and 10-3 M. A less complete attenuation of this di lation was observed when a higher concentration of 10-4 M chlorpheniramine was administered. Data from in vivo pial window preparations (Wahl and Kuschinsky, 1979; Gross et aI., 1981b) , whole brain cerebral blood flow determinations after intraca rotid histamine infusion (Gross et aI., 1981a) , and caudate nucleus blood flow determinations during intraventricular histamine infusion (De Ley et aI., 1982) indicate that the abluminal surface of cerebral arterioles is populated by H2 receptors, whereas HI receptors are principally located on the endothelial surface (Gross, 1981 (Gross, , 1984 . This organization of histamine receptors appears to parallel that ob served in larger systemic arteries, where HI re ceptors are preferentially found in inner smooth muscle cell layers and H2 receptors in outer smooth muscle cell layers (Powell and Brody, 1976) . In the carotid infusion studies of Gross et al. (1981a) , both HI and H2 blockers attenuated the response of the cerebral circulation to histamine. With periadventi tial histamine administration, however, the cerebral arteriolar response is blocked principally by H2 re ceptor blockers and not by HI blockers (Wahl and Kuschinsky, 1979; Gross, 1981b) . The findings of the present study support the hypothesis of Gross (1981 Gross ( , 1984 ) that the one smooth muscle cell layer of intracerebral arterioles is populated with H2 re ceptors, whereas the endothelium may have HI and/or H2 receptors. The role of the endothelium in mediating the his taminergic response in intracerebral arterioles could not be directly assessed in this study. We have examined a number of possible procedures for removing the endothelium in these vessels, in cluding perfusion with albumin-free physiological saline solution, Triton X-100 infusion, perfusion with collagenase, and air insufflation. Although en dothelial cells are at least partially removed by some of these procedures, the remaining smooth muscle cells are unresponsive in our studies of this preparation so far. Nonetheless, acetylcholine, va soactive intestinal peptide, and bradykinin all pro duce vasodilation of arteries in this preparation (unpublished observations), suggesting that the en dothelium is intact and capable of modulating smooth muscle function.
J Cereb Blood Flow Metab, Vol. 7, No.3, 1987 In most in vitro studies of isolated, nonvascular, and extracranial vascular smooth muscle prepara tions, histamine produces contraction associated with increased action potential discharge (in some muscles) and depolarization (Bolton, 1979) . In these studies, vasodilation is more difficult to ex amine because the smooth muscle must be pre treated with norepinephrine or some other va so constricting agonist before any dilation occurs. Nevertheless, a common effect of histamine is smooth muscle contraction in a variety of large vessel sites, including the coronary, renal, femoral, carotid, mesenteric, and pulmonary arteries and the jugular, portal, and caval veins (Altura and Halevy, 1978) . Cat middle cerebral artery has been var iously reported to constrict or dilate (Nielsen and Owman, 1971; Edvinsson and Owman, 1975) . These in vitro data from large vessels contrast with data from the microcirculation, where histamine is almost exclusively a dilator of vessels with diam eters less than 80 j-1m (Altura and Halevy, 1978) . The cellular mechanism of histamine action in rat uterus relaxation appears to involve a rise in cel lular cyclic AMP (Mitznegg et aI., 1975) . As norepi nephrine does not produce significant effects on penetrating intracerebral arteriole diameter at pH 7.30 (Dacey and Duling, 1984) , it is unlikely that histaminergic modulation of transmitter release from sympathetic nerves is playing a significant role in the observations made in the present study.
